SurModics, Inc. (SRDX) Tops Q1 EPS by 11c; Boosts FY13 EPS Outlook
Tweet
Share
E-mailGet Alerts SRDX Hot Sheet
Price: $26.42 -2.15%
Revenue Growth %: +6.5%
Financial Fact:
Net income (loss): 2.64M
Today's EPS Names:
CWD, VUZI, INSE, More
Revenue Growth %: +6.5%
Financial Fact:
Net income (loss): 2.64M
Today's EPS Names:
CWD, VUZI, INSE, More
Join SI Premium – FREE
SurModics, Inc. (NASDAQ: SRDX) reported Q1 EPS of $0.29, $0.11 better than the analyst estimate of $0.18. Revenue for the quarter came in at $13.9 million versus the consensus estimate of $13.63 million.
SurModics, Inc. sees FY2013 EPS of $0.86-0.99, versus prior guidance of $0.75-0.87 and the consensus of $0.82.
For earnings history and earnings-related data on SurModics, Inc. (SRDX) click here.
SurModics, Inc. sees FY2013 EPS of $0.86-0.99, versus prior guidance of $0.75-0.87 and the consensus of $0.82.
For earnings history and earnings-related data on SurModics, Inc. (SRDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Charles Schwab (SCHW) EPS edges past estimates, revenue up sequentially but dips YoY
- WRAP Technologies (WRAP) Provides Update on Operations and Timing of Q4 Report
- Biomerica (BMRA) Issues Update on inFoods IBS Expansion
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
